KELLY GALLO: Open Payments
NPI 1043767874 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$296 in 13 payments from 8 companies in 2025. Trend: 2023 $1,451 · 2024 $277 · 2025 $296
Food & beverage: $296
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 6 | $145 |
| ABBVIE INC. | 1 | $29 |
| Astellas Pharma US Inc | 1 | $27 |
| Exeltis, USA Inc. | 1 | $22 |
| MILLICENT US INC | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Baxter Healthcare | 1 | $18 |
| Resmed Corp | 1 | $17 |
Products named: MYFEMBREE, LO LOESTRIN FE, Veozah, SLYND, FEMRING, Mirena, PERCLOT, AIRSENSE.
Industry payments across FL — which companies pay providers there.
